Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  560 results for ""BISPECIFIC antibodies""

Your Filters

Publisher : nature publishing group
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.

  • Authors : Peña M; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/therapy ; Hematopoietic Stem Cell Transplantation*

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Nov; Vol. 58 (11), pp. 1282-1285. Date of Electronic Publication: 2023 Aug 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The expanding success of T cell-engaging bispecific antibodies.

  • Authors : Bargou RC; Comprehensive Cancer Center Mainfranken and Bavarian Cancer Research Center (BZKF), University Hospital Würzburg, Würzburg, Germany. .

Subjects: T-Lymphocytes* ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use; Lymphocyte Activation

  • Source: Nature cancer [Nat Cancer] 2023 Aug; Vol. 4 (8), pp. 1054-1055.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Report

Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages.

  • Authors : Ren P; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.; System Biology Institute, Yale University, West Haven, CT, USA.

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; COVID-19*; Humans

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Jul 31; Vol. 8 (1), pp. 281. Date of Electronic Publication: 2023 Jul 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction.

  • Authors : Himmels P; Department of Molecular Oncology, Genentech, South San Francisco, CA, USA.; Nguyen TTT

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: EMBO reports [EMBO Rep] 2023 Mar 06; Vol. 24 (3), pp. e55532. Date of Electronic Publication: 2023 Jan 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Bispecific antibodies seek out colon cancer stem cells.

  • Authors : Goto N; Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.; Yilmaz ÖH

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Colonic Neoplasms*; Humans

  • Source: Nature cancer [Nat Cancer] 2022 Apr; Vol. 3 (4), pp. 379-380.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting.

  • Authors : Salomon R; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.; Rotem H

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy; CD40 Antigens

  • Source: Nature cancer [Nat Cancer] 2022 Mar; Vol. 3 (3), pp. 287-302. Date of Electronic Publication: 2022 Feb 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

A new approach to produce IgG 4 -like bispecific antibodies.

  • Authors : Zhao C; School of Pharmacy, Fudan University, Shanghai, 201203, China.; China State Institute of Pharmaceutical Industry, Shanghai, 201203, China.

Subjects: Antibodies, Bispecific/Antibodies, Bispecific/Antibodies, Bispecific/*biosynthesis ; Immunoglobulin G/Immunoglobulin G/Immunoglobulin G/*biosynthesis; Amino Acid Substitution

  • Source: Scientific reports [Sci Rep] 2021 Sep 20; Vol. 11 (1), pp. 18630. Date of Electronic Publication: 2021 Sep 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning.

  • Authors : Haber L; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, 10591, USA. .; Olson K

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacokinetics ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology

  • Source: Scientific reports [Sci Rep] 2021 Jul 13; Vol. 11 (1), pp. 14397. Date of Electronic Publication: 2021 Jul 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies.

  • Authors : Yang C; Department of Gynecology Oncology, The Tumor Hospital, Harbin Medical University, Harbin, P.R. China.; Lou G

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antineoplastic Agents, Immunological*; Immunotherapy

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2021 Jun 03; Vol. 6 (1), pp. 219. Date of Electronic Publication: 2021 Jun 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies Exploits Differential Chain Expression and Affinity Capture.

  • Authors : Nesspor TC; Biologics Discovery, Janssen Research & Development, LLC, Spring House, PA, 19477, USA.; Kinealy K

Subjects: Antibodies, Bispecific/Antibodies, Bispecific/Antibodies, Bispecific/*chemistry ; Immunoglobulin Fab Fragments/Immunoglobulin Fab Fragments/Immunoglobulin Fab Fragments/*chemistry ; Protein Engineering/Protein Engineering/Protein Engineering/*methods

  • Source: Scientific reports [Sci Rep] 2020 May 05; Vol. 10 (1), pp. 7557. Date of Electronic Publication: 2020 May 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  560 results for ""BISPECIFIC antibodies""